Cargando…

460. SARS-CoV-2 Infection-Induced Antibody Seroprevalence in Previously Infected Persons with Immunocompromising Conditions — United States, 2020–2022

BACKGROUND: People with immunocompromising conditions (IC) are at increased risk of severe COVID-19 and death. These individuals show weaker immunogenicity following vaccination than individuals without IC, yet immunogenicity after SARS-CoV-2 infection is poorly understood. To address this gap, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bratcher, Anna, Jones, Jefferson M, Harris, Aaron, Clarke, Kristie E N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677318/ http://dx.doi.org/10.1093/ofid/ofad500.530

Ejemplares similares

Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022
por: Clarke, Kristie E.N., et al.
Publicado: (2022)

Opportunistic infections in persons with HIV or other immunocompromising conditions.
por: Kaplan, J E, et al.
Publicado: (2001)

Respiratory Viral Infections in Immunocompetent and Immunocompromised Persons
por: Couch, MD, Robert B., et al.
Publicado: (1997)

Case report of Usutu virus infection in an immunocompromised patient in Italy, 2022
por: Gaibani, Paolo, et al.
Publicado: (2023)

Anti-HDV seroprevalance among patients with previous HBV infection
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Molecular characterization of antibodies bearing Id-460. II. Molecular basis for Id-460 expression
Publicado: (1985)

Seroprevalence of Antibodies to SARS-CoV-2 in Rural Households in Eastern Uganda, 2020-2022
por: Briggs, Jessica, et al.
Publicado: (2023)

Infections in the Immunocompromised
por: Cant, Andrew, et al.
Publicado: (2009)

Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States—October 25, 2020–February 26, 2022
por: Wiegand, Ryan E., et al.
Publicado: (2022)

Infections in the Immunocompromised Host
por: Bin-Hussain, Ibrahim
Publicado: (2012)

Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022
por: Solastie, Anna, et al.
Publicado: (2023)

Isolation of Novel Mycobacterium Species from Skin Infection in an Immunocompromised Person
por: Mei, You-Ming, et al.
Publicado: (2021)

460. Point-of-Care, In-Home SARS-CoV-2 IgG Antibody Testing to Assess Seroprevalence in At-Risk Health Care Workers
por: Meissner, Eric G, et al.
Publicado: (2020)

Seroprevalence of arthropod-borne bacterial infections in homeless individuals in Hamburg in 2020
por: Heinrich, Fabian, et al.
Publicado: (2023)

Toxoplasma gondii Infection in Immunocompromised Patients in Iran (2013–2022): A Systematic Review and Meta-Analysis
por: Teimouri, Aref, et al.
Publicado: (2022)

Viral Infections in Immunocompromised Patients
por: Englund, Janet, et al.
Publicado: (2011)

Immunocompromised hosts: Infections and biomarkers
por: Kulkarni, Atul P.
Publicado: (2013)

Management of immunocompromised and infected animals
por: Mossmann, Horst, et al.
Publicado: (2002)

Cellular basis of regulation of expression of idiotype. II. Immunity to anti-MOPC-460 idiotype antibodies increases the level of anti- trinitrophenyl antibodies bearing 460 idiotypes
Publicado: (1979)

Increased SARS-CoV-2 seroprevalence and spread of infection without awareness among healthcare workers through 2020–2022 in a Japanese medical center
por: Kanamori, Rie, et al.
Publicado: (2023)

Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022
por: Kinoshita, Ryo, et al.
Publicado: (2023)

460. Ceftriaxone vs. Standard of Care for Definitive Treatment of Methicillin-Susceptible Staphylococcus aureus Infections
por: Snawerdt, Jessica, et al.
Publicado: (2019)

Expression of an idiotype (Id-460) during in vivo anti-dinitrophenyl antibody responses. III. Detection of Id-460 in normal serum that does not bind dinitrophenyl
Publicado: (1981)

Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020–March 2022
por: Yamayoshi, Seiya, et al.
Publicado: (2022)

Cytomegalovirus infection of the thyroid in immunocompromised adults.
por: Frank, T. S., et al.
Publicado: (1987)

Emerging fungal infections in immunocompromised patients
por: Low, Chian-Yong, et al.
Publicado: (2011)

Toxoplasma gondii infection in immunocompromised individuals
por: Csep, Andrei, et al.
Publicado: (2013)

Cytomegalovirus Cutaneous Infection in an Immunocompromised Patient
por: Fasanya, Adebayo A, et al.
Publicado: (2016)

Cutaneous fungal infection in an immunocompromised host
por: Sotello, David, et al.
Publicado: (2017)

Respiratory Infection in Immunocompromised Neutropenic Patients
por: Crawford, S. W.
Publicado: (2010)

1 Management of Immunocompromised and Infected Animals
por: Mossmann, H, et al.
Publicado: (1998)

Aeromonas hydrophilia Infection in an Immunocompromised Host
por: Zhao, Yi, et al.
Publicado: (2021)

Strongyloides stercoralis Infection in Immunocompromised Host
por: Sharma, Neha, et al.
Publicado: (2022)

Disseminated Salmonella Infection in an Immunocompromised Patient
por: Small, Coulter, et al.
Publicado: (2022)

Primary Spinal Infections in Patients With Hematologic Immunocompromising Conditions: A Systematic Literature Review
por: Devico Marciano, Naomie, et al.
Publicado: (2023)

Seroprevalence and Risk Factors for Equine West Nile Virus Infections in Eastern Germany, 2020
por: Ganzenberg, Stefanie, et al.
Publicado: (2022)

U.S. CDC support to international SARS-CoV-2 seroprevalence surveys, May 2020–February 2022
por: Ben Hamida, Amen, et al.
Publicado: (2022)

Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
por: Falender, Rebecca A., et al.
Publicado: (2023)

Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person
por: Munnink, Bas B. Oude, et al.
Publicado: (2022)

High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022
por: Groenheit, Ramona, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1b1lcetvqfthuvnekb89kb173c